---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-019064"
form_type: "8-K"
ticker: "NXTS"
cik: "0001789192"
company_name: "Nexentis Technologies Inc."
filed_at: "2025-10-23T23:59:59+00:00"
generated_at: "2026-05-17T02:32:58.368029+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# N2OFF closes acquisition of MitoCareX, issuing stock and $700K cash for 100% of biotech

## Summary
- Acquired 100% of MitoCareX, a drug discovery company targeting resistant cancers including pancreatic and non-small cell lung cancer.
- Consideration: $700,000 cash to SciSparc and ~1.17M shares (40% of N2OFF fully diluted capital) to the Sellers.
- Sellers entitled to 30% of N2OFF financing proceeds (capped at $1.6M) for 5 years and milestone issuances up to 25% additional stock.
- Board overlap: N2OFF Chairman Amitay Weiss and Director Liat Sidi also serve on SciSparc's board.

## SEC filing metadata
- accession: 0001493152-25-019064
- form_type: 8-K
- ticker: NXTS
- cik: 0001789192
- company_name: Nexentis Technologies Inc.
- filed_at: 2025-10-23T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1789192/000149315225019064/0001493152-25-019064-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1789192/000149315225019064/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-019064
- JSON: https://secwatch.observer/filing/0001493152-25-019064.json
- Plain text: https://secwatch.observer/filing/0001493152-25-019064.txt

## Source-grounded claims
- claim_id: a777b6dd9ce6a01d9d51095207c29d5315f523c7
  claim: Nexentis Technologies Inc. completed an acquisition involving SciSparc Ltd, Dr. Alon Silberman, and Prof. Ciro Leonardo Pierri (collectively, the Sellers) (closed 2025-10-20).
  evidence_excerpt: On October 20, 2025, upon the satisfaction of the remaining closing conditions in the Agreement, the Acquisition closed (the "Closing").
  evidence_url: https://www.sec.gov/Archives/edgar/data/1789192/000149315225019064/0001493152-25-019064-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.